Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 6/20 | 0.34 |
| ▸ | PPARG known ✓ | P37231 | 1/20 | 0.33 |
| ▸ | GRIN2D known ✓ | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B known ✓ | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 known ✓ | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A known ✓ | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B known ✓ | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C known ✓ | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A known ✓ | Q8TCU5 | 1/20 | 0.32 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.31 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.31 |
| ▸ | CHRNB4 known ✓ | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 known ✓ | P32297 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 6/20 | 0.34 |
| ▸ | CA1 | P00915 | 6/20 | 0.34 |
| ▸ | CA9 | Q16790 | 6/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4269574 | 1.00 | TSHR (0.46) | TSHRHCAR2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL406007 | 1.00 | TSHR (0.46) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL769926 | 0.97 | — | — | |
| SCHEMBL215572 | 0.97 | — | — | |
| SCHEMBL4269578 | 0.97 | — | — | |
| SCHEMBL27315313 | 0.94 | TSHR (0.46) | TSHRHCAR2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL21612233 | 0.92 | TSHR (0.43) | TSHRHCAR2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL3926493 | 0.92 | TSHR (0.43) | TSHRHCAR2CA12CA1CA2 | |
| Methylene Chloride SCHEMBL28185523 | 0.91 | LMNA (0.40) | TSHRHCAR2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL28144996 | 0.89 | TSHR (0.37) | TSHRHCAR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1068 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025389-A | Phosphoramidate nucleoside drug compound, and synthetic method and drug application thereof | 河南师范大学 | 2025-05-23 | — | — | CN | claimed |
| CN-118978559-A | Synthesis method and medicinal application of phosphoramidate nucleoside prodrug | 河南师范大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118745201-A | Synthesis method of tenofovir alafenamide and liquid phase detection method thereof | 浙江海翔药业股份有限公司 | 2024-10-08 | — | — | CN | claimed |
| CN-118745198-A | Preparation method of aryloxy phosphoramidate compound | 北京凯因格领生物技术有限公司 | 2024-10-08 | — | — | CN | claimed |
| CN-116642978-A | Method for measuring related substances of L-alanine isopropyl ester hydrochloride by adopting non-derivatization HPLC method | 福建省福抗药业股份有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-116583529-A | Abiraterone derivative and preparation method thereof | 上海喀露蓝科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-116338067-A | Method for separating and measuring enantiomer in L-alanine isopropyl ester hydrochloride by high performance liquid chromatography | 南京海辰药业股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-113484430-B | Method for measuring related substances of L-alanine isopropyl ester hydrochloride by adopting high performance liquid chromatography | 重庆医药高等专科学校 | 2023-06-20 | — | — | CN | claimed |
| CN-112321643-B | Post-treatment method of propiophenone tenofovir solution and preparation method of propiophenone tenofovir | 广药白云山化学制药(珠海)有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-112782311-B | HPLC (high performance liquid chromatography) determination method for L-isopropyl alanine in propane phenol fumarate tenofovir | 南京百泽医药科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-106518694-A | Novel preparation method of L-alanine isopropyl ester hydrochloride | 浙江金伯士药业有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-106432327-A | Method for preparing sofosbuvir key intermediate | 江苏福瑞生物医药有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106432328-A | Method for preparing sofosbuvir intermediate | 江苏福瑞生物医药有限公司 | 2017-02-22 | — | — | CN | claimed |
| WO-2016196735-A2 | IMPROVED PROCESSES FOR THE PREPARATION OF SOFOSBUVIR AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2016-12-08 | — | — | WO | claimed |
| CN-205188179-U | L - alanine isopropyl ester hydrochloric acid reaction dewatering system | SULI PHARMACEUTICAL TECH JIANGYIN CO LTD | 2016-04-27 | — | — | CN | claimed |
| CN-104610404-B | A kind of preparation method of ribofuranose phosphate derivative | Nantong Chang You medicine company Science and Technology Ltd. (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-104761582-A | Method for preparation of N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxy phosphoryl]-L-alanine isopropyl ester | SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP CO LTD | 2015-07-08 | — | — | CN | claimed |
| CN-104610404-A | Preparation method of ribofuranose phosphate derivative | NANTONG CHANGYOU PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-05-13 | — | — | CN | claimed |
| WO-2015040640-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF TENOFOVIR ALAFENAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LAURUS LABS PRIVATE LIMITED (IN) | 2015-03-26 | — | — | WO | claimed |
| CN-104230985-A | Preparation method of (s)-2-[(s)-(4-nitro-phenoxy)-phenoxy-phosphoryl amino] isopropyl propionate | BEIJING THTD PHARMACEUTICAL TECHNOLOGY CO LTD | 2014-12-24 | — | — | CN | claimed |